These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 26206120)

  • 1. ω-3 Polyunsaturated Fatty Acids Effects on the Cardiometabolic Syndrome and their Role in Cardiovascular Disease Prevention: An Update from the Recent Literature.
    Colussi G; Catena C; Sechi LA
    Recent Adv Cardiovasc Drug Discov; 2014; 9(2):78-96. PubMed ID: 26206120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of ω3 long-chain polyunsaturated fatty acids in reducing cardio-metabolic risk factors.
    Abeywardena MY; Patten GS
    Endocr Metab Immune Disord Drug Targets; 2011 Sep; 11(3):232-46. PubMed ID: 21831036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Clinical Trials Shed New Light on the Cardiovascular Benefits of Omega-3 Fatty Acids.
    Kris-Etherton PM; Richter CK; Bowen KJ; Skulas-Ray AC; Jackson KH; Petersen KS; Harris WS
    Methodist Debakey Cardiovasc J; 2019; 15(3):171-178. PubMed ID: 31687095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials.
    O'Mahoney LL; Matu J; Price OJ; Birch KM; Ajjan RA; Farrar D; Tapp R; West DJ; Deighton K; Campbell MD
    Cardiovasc Diabetol; 2018 Jul; 17(1):98. PubMed ID: 29981570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 fatty acids: from biochemistry to their clinical use in the prevention of cardiovascular disease.
    Colussi G; Catena C; Baroselli S; Nadalini E; Lapenna R; Chiuch A; Sechi LA
    Recent Pat Cardiovasc Drug Discov; 2007 Jan; 2(1):13-21. PubMed ID: 18221098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Cardiovascular Events with Omega-3 Polyunsaturated Fatty Acids and the Mechanism Involved.
    Watanabe Y; Tatsuno I
    J Atheroscler Thromb; 2020 Mar; 27(3):183-198. PubMed ID: 31582621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on marine omega-3 fatty acids: management of dyslipidemia and current omega-3 treatment options.
    Weintraub H
    Atherosclerosis; 2013 Oct; 230(2):381-9. PubMed ID: 24075771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
    Singh S; Arora RR; Singh M; Khosla S
    Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertriglyceridemia and omega-3 fatty acids: Their often overlooked role in cardiovascular disease prevention.
    Arca M; Borghi C; Pontremoli R; De Ferrari GM; Colivicchi F; Desideri G; Temporelli PL
    Nutr Metab Cardiovasc Dis; 2018 Mar; 28(3):197-205. PubMed ID: 29397253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do we need 'new' omega-3 polyunsaturated fatty acids formulations?
    Cicero AF; Morbini M; Borghi C
    Expert Opin Pharmacother; 2015 Feb; 16(3):285-8. PubMed ID: 25474717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of omega-3 fatty acids in cardiovascular disease prevention].
    Piñeiro-Corrales G; Lago Rivero N; Culebras-Fernández JM
    Nutr Hosp; 2013; 28(1):1-5. PubMed ID: 23808424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-3 polyunsaturated fatty acids supplementation in patients with diabetes and cardiovascular disease risk: does dose really matter?
    Tenenbaum A; Fisman EZ
    Cardiovasc Diabetol; 2018 Aug; 17(1):119. PubMed ID: 30153832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 fatty acids for cardioprotection.
    Lee JH; O'Keefe JH; Lavie CJ; Marchioli R; Harris WS
    Mayo Clin Proc; 2008 Mar; 83(3):324-32. PubMed ID: 18316000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective Effects of Omega-3 Polyunsaturated Fatty Acids: Dichotomy between Experimental and Clinical Studies.
    Desnoyers M; Gilbert K; Rousseau G
    Mar Drugs; 2018 Jul; 16(7):. PubMed ID: 29996474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 fatty acids and secondary prevention of cardiovascular disease-is it just a fish tale?: comment on “Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease”.
    Hu FB; Manson JE
    Arch Intern Med; 2012 May; 172(9):694-6. PubMed ID: 22493410
    [No Abstract]   [Full Text] [Related]  

  • 16. Omega-3 Fatty Acid Supplementation and Cardiovascular Disease Risk: Glass Half Full or Time to Nail the Coffin Shut?
    Maki KC; Dicklin MR
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 29973554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 polyunsaturated fatty acids and cardiovascular diseases.
    Lavie CJ; Milani RV; Mehra MR; Ventura HO
    J Am Coll Cardiol; 2009 Aug; 54(7):585-94. PubMed ID: 19660687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 polyunsaturated fatty acids: is their future VITALized or REDUCEd?
    Gajos G
    Cardiovasc Res; 2019 May; 115(6):e58-e60. PubMed ID: 31077585
    [No Abstract]   [Full Text] [Related]  

  • 19. Indications for Omega-3 Long Chain Polyunsaturated Fatty Acid in the Prevention and Treatment of Cardiovascular Disease.
    Nestel P; Clifton P; Colquhoun D; Noakes M; Mori TA; Sullivan D; Thomas B
    Heart Lung Circ; 2015 Aug; 24(8):769-79. PubMed ID: 25936871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of marine omega-3 fatty acids.
    Saravanan P; Davidson NC; Schmidt EB; Calder PC
    Lancet; 2010 Aug; 376(9740):540-50. PubMed ID: 20638121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.